Cindy R. Tahl

Overview

Cindy R. Tahl received an average of $3M in total compensation, including $386K in salary, at Fate Therapeutics from 2018 to 2021.

Source: SEC filings on April 25, 2022, April 21, 2021, and March 22, 2019.

Related executives

We found ten more executives who work or worked at Fate Therapeutics.

J Wolchko

Fate Therapeutics

Chief Executive Officer

Mark Plavsic

Fate Therapeutics

Chief Technology Officer

Bahram Valamehr

Fate Therapeutics

Chief Research and Development Officer

Yu-Waye Chu

Fate Therapeutics

Chief Medical Officer

Edward Dulac

Fate Therapeutics

Chief Financial Officer

Daniel Shoemaker

Fate Therapeutics

Chief Scientific Officer

Christopher Storgard

Fate Therapeutics

Chief Medical Officer

Stewart Abbot

Fate Therapeutics

Chief Development Officer

News

You may also like